Inactive Instrument

Irwin Naturals Inc. Stock Canadian Securities Exchange

IWIN

CA46414Q1054

Valuation: Irwin Naturals Inc.

Market Cap	483K 414K 387K 354K 668K 46.25M 675K 4.58M 1.78M 23.22M 1.81M 1.77M 76.84M	P/E 2021	105x	P/E 2022	-0.91x
Enterprise Value	21.01M 18.01M 16.85M 15.4M 29.06M 2.01B 29.37M 199M 77.51M 1.01B 78.89M 77.18M 3.34B	EV / Sales 2021	0.13x	EV / Sales 2022	0.31x
Free-Float	1.04%	Yield 2021 *	-	Yield 2022	-

* Estimated data More valuation ratios

Managers and Directors: Irwin Naturals Inc.

Manager	Title	Age	Since
Klee Irwin CEO	Chief Executive Officer	60	01/01/1994
Mark Green DFI	Director of Finance/CFO	-	08/03/2024

Director	Title	Age	Since
Klee Irwin CHM	Chairman	60	01/01/1994

More insiders

IN Holdings Canada Inc., formerly Irwin Naturals Inc., is a nutraceutical company. It is leveraging its brand into both the cannabis and psychedelic sectors. It manufactures vitamins and other health supplements. It also owns and operates mental health clinics and an advertising company specializing in ketamine clinics in the United States. Its national chain of psychedelic mental health clinics is called Irwin Naturals Emergence. Its vitamins and supplements include better sleep; brain, mood & stress; cleanse + detox; immune support; men's health; multi-vitamins; RED (nitric oxide boost); sexual health; testosterone boosters; weight management, and women's health. Its cannabidiol (CBD) products include CBD +Turmeric Extra Strength, CBD +Melatonin Gummies 15 mg, CBD Oils 250 mg (unflavored), CBD Balm 1000 mg (Arnica), CBD Balm 1000 mg (lemongrass), CBD Soft Gels 30 mg and CBD +Power to Sleep. Its portfolio of products is available in more than 100,000 retail doors across North America.

Employees

Sector

Pharmaceuticals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Date	Insider	Type	Main position	Quantity	% Market Cap.
16/08/21	Klee Irwin	Other	Chief Executive Officer	0	-
16/08/21	Klee Irwin	Other	Chief Executive Officer	0	-
16/08/21	Klee Irwin	Marche	Chief Executive Officer	18,240	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IRWIN NATURALS INC.	-.--%	+46.34%	-	-	708K
ELI LILLY AND COMPANY	-0.67%	+5.39%	+75.21%	+127.54%	1,111B
JOHNSON & JOHNSON	+1.04%	+4.07%	+52.29%	+65.39%	658B
ABBVIE INC.	-0.17%	+5.67%	+25.60%	+80.40%	467B
ROCHE HOLDING AG	-1.38%	+4.02%	+41.64%	+42.38%	369B
NOVARTIS AG	-0.52%	+2.72%	+24.32%	+41.06%	301B
ASTRAZENECA PLC	-1.06%	+4.76%	+1.19%	+12.65%	256B
AMGEN INC.	+1.03%	+5.83%	+51.11%	+72.96%	240B
NOVO NORDISK A/S	-0.53%	+2.34%	-17.77%	-53.66%	207B
GILEAD SCIENCES, INC.	+0.42%	+5.63%	+27.86%	+92.24%	182B
Average	-0.18%	+4.49%	+31.27%	+53.44%	421.22B
Weighted average by Cap.	-0.23%	+4.68%	+43.95%	+73.01%

	2021	2022
Net sales	100M 85.99M 80.45M 73.55M 139M 9.61B 140M 952M 370M 4.82B 377M 369M 15.96B	89.47M 76.68M 71.73M 65.58M 124M 8.57B 125M 849M 330M 4.3B 336M 329M 14.23B
Net income	8.62M 7.38M 6.91M 6.31M 11.92M 825M 12.04M 81.73M 31.78M 414M 32.35M 31.65M 1.37B	-3.99M -3.42M -3.2M -2.93M -5.52M -382M -5.58M -37.87M -14.73M -192M -14.99M -14.66M -635M
Net Debt	9.35M 8.02M 7.5M 6.86M 12.94M 896M 13.07M 88.73M 34.5M 450M 35.12M 34.36M 1.49B	20.53M 17.59M 16.46M 15.05M 28.39M 1.97B 28.7M 195M 75.73M 987M 77.08M 75.41M 3.27B

Irwin Naturals Inc. Stock Canadian Securities Exchange

Stocks

IWIN

CA46414Q1054

Pharmaceuticals

Valuation: Irwin Naturals Inc.

Managers and Directors: Irwin Naturals Inc.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile